These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31970214)

  • 1. Hyperphosphorylated Tau, Increased Adenylate Cyclase 5 (ADCY5) Immunoreactivity, but No Neuronal Loss in ADCY5-Dyskinesia.
    Chen DH; Latimer CS; Spencer M; Karna P; Gonzalez-Cuyar LF; Davis MY; Keene CD; Bird TD; Raskind WH
    Mov Disord Clin Pract; 2020 Jan; 7(1):70-77. PubMed ID: 31970214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations.
    Chen DH; Méneret A; Friedman JR; Korvatska O; Gad A; Bonkowski ES; Stessman HA; Doummar D; Mignot C; Anheim M; Bernes S; Davis MY; Damon-Perrière N; Degos B; Grabli D; Gras D; Hisama FM; Mackenzie KM; Swanson PD; Tranchant C; Vidailhet M; Winesett S; Trouillard O; Amendola LM; Dorschner MO; Weiss M; Eichler EE; Torkamani A; Roze E; Bird TD; Raskind WH
    Neurology; 2015 Dec; 85(23):2026-35. PubMed ID: 26537056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADCY5-related dyskinesia - case series with literature review.
    Kozon K; Łysikowska W; Olszewski J; Milanowski Ł; Figura M; Mazurczak T; Hoffman-Zacharska D; Koziorowski D
    Neurol Neurochir Pol; 2024; 58(2):161-166. PubMed ID: 38230756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADCY5-Related Dyskinesia: Improving Clinical Detection of an Evolving Disorder.
    Vijiaratnam N; Bhatia KP; Lang AE; Raskind WH; Espay AJ
    Mov Disord Clin Pract; 2019 Sep; 6(7):512-520. PubMed ID: 31538084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoping Review on ADCY5-Related Movement Disorders.
    Menon PJ; Nilles C; Silveira-Moriyama L; Yuan R; de Gusmao CM; Münchau A; Carecchio M; Grossman S; Grossman G; Méneret A; Roze E; Pringsheim T
    Mov Disord Clin Pract; 2023 Jul; 10(7):1048-1059. PubMed ID: 37476318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic insights into ADCY5-associated disease.
    Chang FC; Westenberger A; Dale RC; Smith M; Pall HS; Perez-Dueñas B; Grattan-Smith P; Ouvrier RA; Mahant N; Hanna BC; Hunter M; Lawson JA; Max C; Sachdev R; Meyer E; Crimmins D; Pryor D; Morris JG; Münchau A; Grozeva D; Carss KJ; Raymond L; Kurian MA; Klein C; Fung VS
    Mov Disord; 2016 Jul; 31(7):1033-40. PubMed ID: 27061943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation effect in genetic dyskinetic cerebral palsy: The case of ADCY5- related disease.
    Cif L; Demailly D; Gehin C; Chan Seng E; Dornadic M; Huby S; Poulen G; Roubertie A; Villessot M; Roujeau T; Coubes P
    Mol Genet Metab; 2023 Jan; 138(1):106970. PubMed ID: 36610259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADCY5-related dyskinesia: a case report.
    Chen SY; Ho CJ; Lu YT; Lin CH; Tsai MH
    Neurol Res Pract; 2022 Aug; 4(1):39. PubMed ID: 35965335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders.
    Bohlega SA; Abou-Al-Shaar H; AlDakheel A; Alajlan H; Bohlega BS; Meyer BF; Monies D; Cupler EJ; Al-Saif AM
    Parkinsonism Relat Disord; 2019 Jul; 64():145-149. PubMed ID: 30975617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update on the Phenotype, Genotype and Neurobiology of ADCY5-Related Disease.
    Ferrini A; Steel D; Barwick K; Kurian MA
    Mov Disord; 2021 May; 36(5):1104-1114. PubMed ID: 33934385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia.
    Carapito R; Paul N; Untrau M; Le Gentil M; Ott L; Alsaleh G; Jochem P; Radosavljevic M; Le Caignec C; David A; Damier P; Isidor B; Bahram S
    Mov Disord; 2015 Mar; 30(3):423-7. PubMed ID: 25545163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.
    Carecchio M; Mencacci NE; Iodice A; Pons R; Panteghini C; Zorzi G; Zibordi F; Bonakis A; Dinopoulos A; Jankovic J; Stefanis L; Bhatia KP; Monti V; R'Bibo L; Veneziano L; Garavaglia B; Fusco C; Wood N; Stamelou M; Nardocci N
    Parkinsonism Relat Disord; 2017 Aug; 41():37-43. PubMed ID: 28511835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep in
    Méneret A; Roze E; Maranci JB; Dodet P; Doummar D; Riant F; Tranchant C; Fraix V; Anheim M; Ekmen A; McGovern E; Vidailhet M; Arnulf I; Leu-Semenescu S
    J Clin Sleep Med; 2019 Jul; 15(7):1021-1029. PubMed ID: 31383240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study.
    Méneret A; Mohammad SS; Cif L; Doummar D; DeGusmao C; Anheim M; Barth M; Damier P; Demonceau N; Friedman J; Gallea C; Gras D; Gurgel-Giannetti J; Innes EA; Necpál J; Riant F; Sagnes S; Sarret C; Seliverstov Y; Paramanandam V; Shetty K; Tranchant C; Doulazmi M; Vidailhet M; Pringsheim T; Roze E
    Mov Disord; 2022 Jun; 37(6):1294-1298. PubMed ID: 35384065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADCY5 mutations are another cause of benign hereditary chorea.
    Mencacci NE; Erro R; Wiethoff S; Hersheson J; Ryten M; Balint B; Ganos C; Stamelou M; Quinn N; Houlden H; Wood NW; Bhatia KP
    Neurology; 2015 Jul; 85(1):80-8. PubMed ID: 26085604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.
    Heckman MG; Kasanuki K; Brennan RR; Labbé C; Vargas ER; Soto AI; Murray ME; Koga S; Dickson DW; Ross OA
    Mov Disord; 2019 Sep; 34(9):1325-1332. PubMed ID: 31234228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADCY5-related dyskinesia presenting as familial myoclonus-dystonia.
    Douglas AG; Andreoletti G; Talbot K; Hammans SR; Singh J; Whitney A; Ennis S; Foulds NC
    Neurogenetics; 2017 Apr; 18(2):111-117. PubMed ID: 28229249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of theophylline on ADCY5 activation-From cellular studies to improved therapeutic options for ADCY5-related dyskinesia patients.
    Tänzler D; Kipping M; Lederer M; Günther WF; Arlt C; Hüttelmaier S; Merkenschlager A; Sinz A
    PLoS One; 2023; 18(3):e0282593. PubMed ID: 36867608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia.
    Chen YZ; Friedman JR; Chen DH; Chan GC; Bloss CS; Hisama FM; Topol SE; Carson AR; Pham PH; Bonkowski ES; Scott ER; Lee JK; Zhang G; Oliveira G; Xu J; Scott-Van Zeeland AA; Chen Q; Levy S; Topol EJ; Storm D; Swanson PD; Bird TD; Schork NJ; Raskind WH; Torkamani A
    Ann Neurol; 2014 Apr; 75(4):542-9. PubMed ID: 24700542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ADCY5-Associated Dystonia, Chorea, and Hyperkinetic Disorders With Deep Brain Stimulation: A Multicenter Case Series.
    Dy ME; Chang FC; Jesus SD; Anselm I; Mahant N; Zeilman P; Rodan LH; Foote KD; Tan WH; Eskandar E; Sharma N; Okun MS; Fung VS; Waugh JL
    J Child Neurol; 2016 Jul; 31(8):1027-35. PubMed ID: 27052971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.